Disease/Infection News

RSS

White youths less likely to be tested for STI in pediatric emergency department

When adolescent females visit a pediatric emergency department with complaints that may signal a sexually transmitted infection, white youths are less likely to be tested than blacks, according to a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.

30 Apr 2011

ED providers need to assess STI risks in adolescents: Instructor of pediatrics

All adolescent females who show up in the emergency department complaining primarily of lower abdominal pain and/or urinary or genital symptoms should be tested for sexually transmitted infections, according to the authors of a study to be presented Saturday, April 30, at the Pediatric Academic Societies annual meeting in Denver.

30 Apr 2011

WHO highlights global threat of NCDs, need for action at Moscow meeting

Non-communicable diseases are a "slow-moving catastrophe" that could overwhelm even the richest countries without action to address their underlying causes, WHO Director-General Margaret Chan said at the First Global Ministerial Conference on Healthy Lifestyles and Non-communicable Disease Control in Moscow on Thursday, the U.N. News Centre reports.

30 Apr 2011

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

Libya will run out of food within two months unless efforts are stepped up to get shipments into the war-torn country, the World Food Program warned on Thursday, Deustche Presse-Agentur/M&C reports.

30 Apr 2011

Scientists discover how immune cells recognize invading pathogens in the body

Scientists at Cedars-Sinai Medical Center have discovered how a molecular receptor on the surface of white blood cells identifies when invading fungi have established direct contact with the cell surface and pose an infectious threat.

30 Apr 2011

Researchers unravel mechanism behind sickle hemoglobin protection against malaria

The latest issue of the journal Cell carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. In a study that challenges currently held views, researchers at the Instituto Gulbenkian de Ci-ncia, in Portugal, unravel the molecular mechanism whereby sickle cell hemoglobin confers a survival advantage against malaria, the disease caused by Plasmodium infection.

29 Apr 2011

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Vertex Pharmaceuticals Incorporated announced that the Antiviral Drugs Advisory Committee to the U.S. Food and Drug Administration voted unanimously to recommend FDA approval of telaprevir for people with genotype 1 chronic hepatitis C.

29 Apr 2011

Flu vaccination lowers kidney transplant recipients' risk of organ loss and death

Getting vaccinated against the flu lowers kidney transplant recipients' risk of organ loss and death, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology.

29 Apr 2011

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

João Gonçalves, from Faculdade de Farmácia e Instituto de Medicina Molecular, Lisbon, Portugal, to win a Grand Challenges Exploration Award

29 Apr 2011

Study finds low pediatric flu vaccination acceptance rates in Atlanta

A study of H1N1 and seasonal influenza vaccination in a sample of black and Hispanic children in Atlanta found a low rate of vaccine acceptance among parents and caregivers.

29 Apr 2011

New genetic study suspects Armadillos as source of leprosy in the U.S.

A new genetic study on leprosy bacteria reports that armadillos may be a source of infection in the Southern United States.

29 Apr 2011

New innovative pilot project to combat surgical infections

Roughly one out of every 24 patients undergoing surgery acquires a surgical site infection. With 40 million operations performed in the U.S. each year, between 800,000 and 2 million individuals contract these infections annually.

29 Apr 2011

UIC receives federal contract to develop antibiotics against three bacterial infections

Researchers at the University of Illinois at Chicago's Center for Pharmaceutical Biotechnology have been awarded a federal contract for up to $13.8 million to develop antibiotics to treat anthrax, tularemia and plague.

28 Apr 2011

CBI, Children's Rare Disease Network and Global Genes Project partner for Rare Disease Leadership Summit

The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to announce a partnership with the Children's Rare Disease Network and The Global Genes Project for the 6th Annual Rare Disease Leadership Summit coming up July 12 - 13, 2011 at the Doubletree Hotel in Washington, D.C.

28 Apr 2011

PURE Bioscience introduces new Hard Surface disinfectant

PURE Bioscience, Inc., creator of the patented silver dihydrogen citrate antimicrobial, today announced the launch of its proprietary new brand, PURE Hard Surface disinfectant and food contact surface sanitizer at the 2011 California State PTA Annual Convention being held April 28 - May 1 in Long Beach, California.

28 Apr 2011

Hepatitis B virus rebound common in patients receiving nucleoside analogs for chronic hepatitis B

A rebound of the Hepatitis B virus is common in patients receiving nucleoside analogs for chronic hepatitis B, according to a study from U-M hepatologists. But nearly 40% of the rebounds or virological breakthroughs (VBTs) were not related to antiviral drug resistance.

28 Apr 2011

CMA and AFN call federal leaders to modernize Canada Health Act

The Canadian Medical Association and the Assembly of First Nations today called on federal leaders to commit to defending and modernizing the Canada Health Act and enhancing the health of First Nations peoples across Canada.

28 Apr 2011

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Mayes College of Healthcare Business and Policy at University of the Sciences is hosting a panel discussion on hepatitis C prevention and treatment, on Thursday, April 28, 2011, from 5 to 7 p.m.

28 Apr 2011

Researchers begin approved drugs screening for clinical use against rare diseases

Researchers have begun screening the first definitive collection of thousands of approved drugs for clinical use against rare and neglected diseases. They are hunting for additional uses of the drugs hoping to find off-label therapies, for some of the 6,000 rare diseases that afflict 25 million Americans.

28 Apr 2011

TB screening misses immigrants: Study

According to a latest study published in The Lancet, one in five new immigrants to the UK from the Indian subcontinent, and almost a third from sub-Saharan Africa, carried latent tuberculosis (TB).

28 Apr 2011

Disease/Infection News

White youths less likely to be tested for STI in pediatric emergency department

ED providers need to assess STI risks in adolescents: Instructor of pediatrics

WHO highlights global threat of NCDs, need for action at Moscow meeting

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

Scientists discover how immune cells recognize invading pathogens in the body

Researchers unravel mechanism behind sickle hemoglobin protection against malaria

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Flu vaccination lowers kidney transplant recipients' risk of organ loss and death

Portuguese researcher to earn Bill & Melinda Gates Foundation award for new HIV therapy

Study finds low pediatric flu vaccination acceptance rates in Atlanta

New genetic study suspects Armadillos as source of leprosy in the U.S.

New innovative pilot project to combat surgical infections

UIC receives federal contract to develop antibiotics against three bacterial infections

CBI, Children's Rare Disease Network and Global Genes Project partner for Rare Disease Leadership Summit

PURE Bioscience introduces new Hard Surface disinfectant

Hepatitis B virus rebound common in patients receiving nucleoside analogs for chronic hepatitis B

CMA and AFN call federal leaders to modernize Canada Health Act

Panel speakers to discuss hepatitis C prevention, treatment at Mayes College event

Researchers begin approved drugs screening for clinical use against rare diseases

TB screening misses immigrants: Study

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News